Spain Neurovascular Devices Market Size & Outlook

The neurovascular devices market in Spain is expected to reach a projected revenue of US$ 79.5 million by 2030. A compound annual growth rate of 5.1% is expected of Spain neurovascular devices market from 2024 to 2030.
Revenue, 2023 (US$M)
$56.1
Forecast, 2030 (US$M)
$79.5
CAGR, 2024 - 2030
5.1%
Report Coverage
Spain

Spain neurovascular devices market highlights

  • The Spain neurovascular devices market generated a revenue of USD 56.1 million in 2023 and is expected to reach USD 79.5 million by 2030.
  • The Spain market is expected to grow at a CAGR of 5.1% from 2024 to 2030.
  • In terms of segment, cerebral embolization and aneurysm coiling devices was the largest revenue generating device in 2023.
  • Support Devices is the most lucrative device segment registering the fastest growth during the forecast period.


Neurovascular devices market data book summary

Market revenue in 2023USD 56.1 million
Market revenue in 2030USD 79.5 million
Growth rate5.1% (CAGR from 2023 to 2030)
Largest segmentCerebral embolization and aneurysm coiling devices
Fastest growing segmentSupport Devices
Historical data2018 - 2022
Base year2023
Forecast period2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationCerebral Embolization and aneurysm Coiling devices, Cerebral Angioplasty and Stenting Systems, Neurothrombectomy Devices, Support Devices, Trans Radial Access Devices
Key market players worldwideMedtronic PLC, Johnson & Johnson, Penumbra Inc, MicroPort Scientific Corp, Stryker Corp, Terumo Corp, Integra Lifesciences Holdings Corp


Other key industry trends

  • In terms of revenue, Spain accounted for 1.9% of the global neurovascular devices market in 2023.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Europe, Germany neurovascular devices market is projected to lead the regional market in terms of revenue in 2030.
  • Germany is the fastest growing regional market in Europe and is projected to reach USD 203.4 million by 2030.

Cerebral embolization and aneurysm coiling devices was the largest segment with a revenue share of 34.94% in 2023. Horizon Databook has segmented the Spain neurovascular devices market based on cerebral embolization and aneurysm coiling devices, cerebral angioplasty and stenting systems, neurothrombectomy devices, support devices, trans radial access devices covering the revenue growth of each sub-segment from 2018 to 2030.


High incidence of acute ischemic stroke and increasing awareness about the treatment of stroke in Spain are among major factors driving the neurovascular devices market. For instance, as per a report published by Barcelona Institute for Global Health in 2018, around 14.6% of deaths in Spain were caused by acute ischemic stroke.

In addition, favorable healthcare system in Spain may encourage many new players to enter the market, thereby propelling the market growth. 

According to WHO, as compared with other OECD European countries, Spanish healthcare system is well advanced and ensures adoption of innovative technologies. 

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Neurovascular Devices Market Companies

Name Profile # Employees HQ Website

Spain neurovascular devices market size, by device, 2018-2030 (US$M)

Spain Neurovascular Devices Market Outlook Share, 2023 & 2030 (US$M)

Spain neurovascular devices market size, by device, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more